Production (Stage)
ICU Medical, Inc.
ICUI
$128.99
-$1.74-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.42B | 2.38B | 2.34B | 2.30B | 2.26B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.42B | 2.38B | 2.34B | 2.30B | 2.26B |
| Cost of Revenue | 1.57B | 1.56B | 1.57B | 1.56B | 1.52B |
| Gross Profit | 849.65M | 824.78M | 769.11M | 748.18M | 733.08M |
| SG&A Expenses | 638.34M | 638.76M | 634.53M | 620.43M | 611.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.30B | 2.28B | 2.29B | 2.27B | 2.22B |
| Operating Income | 121.25M | 97.41M | 45.91M | 39.23M | 33.87M |
| Income Before Tax | -40.15M | -66.01M | -110.91M | -98.35M | -101.68M |
| Income Tax Expenses | 53.54M | 51.68M | 97.00K | -27.56M | -42.36M |
| Earnings from Continuing Operations | -93.69 | -117.69 | -111.01 | -70.79 | -59.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.69M | -117.69M | -111.01M | -70.79M | -59.31M |
| EBIT | 121.25M | 97.41M | 45.91M | 39.23M | 33.87M |
| EBITDA | 334.68M | 316.92M | 269.59M | 265.61M | 262.43M |
| EPS Basic | -3.83 | -4.83 | -4.57 | -2.92 | -2.45 |
| Normalized Basic EPS | 0.34 | -0.34 | -1.59 | -1.81 | -1.90 |
| EPS Diluted | -3.84 | -4.84 | -4.57 | -2.92 | -2.45 |
| Normalized Diluted EPS | 0.34 | -0.34 | -1.59 | -1.80 | -1.90 |
| Average Basic Shares Outstanding | 97.86M | 97.55M | 97.19M | 96.89M | 96.57M |
| Average Diluted Shares Outstanding | 97.86M | 97.55M | 97.19M | 97.12M | 96.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |